Safety and efficacy of sofosbuvir/velpatasvir in pediatric patients 6 to <18 years old with chronic hepatitis C infection [abstract 748]

Publication Type:

Conference Proceedings

Source:

The Liver Meeting, Boston, Massachusetts (2019)
Top